Trials / Completed
CompletedNCT03527069
Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment
Phase III, National, Multicenter, Randomized, Double Blind Clinical Trial, to Evaluate the Efficacy and Safety of Cipros 10 Association on Dyslipidemia Treatment
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 146 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of Cipros 10 association in the treatment of Dyslipidemia Treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cipros 10 association | oral, once a day. |
| DRUG | Crestor 10 mg | oral, once a day. |
Timeline
- Start date
- 2021-01-29
- Primary completion
- 2024-08-30
- Completion
- 2025-07-25
- First posted
- 2018-05-16
- Last updated
- 2025-12-08
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03527069. Inclusion in this directory is not an endorsement.